SCHEMBL17348452

SCHEMBL17348452

Cc1ncc2cc3c(cc2c1C)OCCO3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 5/20 0.38
HPGD P15428 5/20 0.38
HSD17B10 Q99714 4/20 0.38
GAA P10253 2/20 0.38
TSHR P16473 2/20 0.38
PDE10A Q9Y233 2/20 0.35
RAB9A P51151 6/20 0.34
NPC1 O15118 5/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
ALOX5 P09917 1/20 0.34
CD274 Q9NZQ7 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
PKM P14618 2/20 0.32
TP53 P04637 2/20 0.32
KMT2A Q03164 1/20 0.32
MAPT P10636 2/20 0.32
CTSL P07711 1/20 0.32
CTSB P07858 1/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17348450 0.93 ALDH1A1 (0.37) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL17348447 0.89 ALOX5 (0.44) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL7503031 0.73 CYP2A6 (0.44) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL21508539 0.72 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL11203726 0.67 RPS6KB2 (0.46) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL12732266 0.67 ITGB2 (0.47) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL12313649 0.67 CYP1A2 (0.42) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL24393381 0.67 EGFR (0.46)
SCHEMBL102651 0.66 UHRF1 (0.37) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL18464844 0.64 POLB (0.42) ALDH1A1KDM4EHSD17B10PDE10AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2952503-B1 CARBOXYLIC ACID DERIVATIVES AS HIV REPLICATION INHIBITOR SHIONOGI & CO (JP) 2019-10-23 EP disclosed
US-20150361093-A1 HIV REPLICATION INHIBITOR SHIONOGI & CO., LTD. (JP) 2015-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361093-A1 HIV REPLICATION INHIBITOR RTF2, REV1, PCNA ALDH1A1 4109/4885KDM4E 546/4885HPGD 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.